Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -47,552 | -23,091 | -129,855 | -69,598 | -50,795 |
| Depreciation Amortization | 454 | 269 | 42,690 | 744 | 476 |
| Income taxes - deferred | N/A | N/A | -2,531 | N/A | N/A |
| Accounts receivable | -187 | -188 | 894 | 461 | 933 |
| Other Working Capital | -3,097 | -7,016 | -11,401 | -13,037 | -10,195 |
| Other Operating Activity | 4,995 | 2,524 | 6,807 | 7,396 | 4,429 |
| Operating Cash Flow | $-45,387 | $-27,502 | $-93,396 | $-74,034 | $-55,152 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -2,239 | -2,221 | -2,221 |
| Purchase Of Investment | -15,854 | -3,951 | -160,446 | -107,480 | -84,800 |
| Sale Of Investment | 58,500 | 37,000 | 187,700 | 144,700 | 101,950 |
| Other Investing Activity | 0 | 0 | 1,500 | 0 | 0 |
| Investing Cash Flow | $42,646 | $33,049 | $26,515 | $34,999 | $14,929 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 177 | 0 | 53,064 | 50,351 | 40,296 |
| Financing Cash Flow | $177 | $0 | $53,064 | $50,351 | $40,296 |
| Beginning Cash Position | 45,627 | 45,627 | 59,444 | 59,444 | 59,444 |
| End Cash Position | 43,063 | 51,174 | 45,627 | 70,760 | 59,517 |
| Net Cash Flow | $-2,564 | $5,547 | $-13,817 | $11,316 | $73 |
| Free Cash Flow | |||||
| Operating Cash Flow | -45,387 | -27,502 | -93,396 | -74,034 | -55,152 |
| Capital Expenditure | 0 | N/A | -3,096 | -3,078 | -3,078 |
| Free Cash Flow | -45,387 | -27,502 | -96,492 | -77,112 | -58,230 |